This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antunes, N. T.
Right arrow Articles by Poveda, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antunes, N. T.
Right arrow Articles by Poveda, J. B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2007, p. 3452-3454, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.00420-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

In Vitro Susceptibilities of Mycoplasma putrefaciens Field Isolates{triangledown}

N. T. Antunes,1* M. M. Tavío,2 P. Mercier,3 R. D. Ayling,4 W. Al-Momani,5 P. Assunção,1 R. S. Rosales,1 and J. B. Poveda1

Unidad de Epidemiología y Medicina Preventiva, Instituto Universitario de Sanidad Animal (IUSA), Universidad de Las Palmas de Gran Canaria, Arucas, Spain,1 Microbiología, Departamento de Ciencias Clínicas, Facultad de Medicina, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain,2 Agence Française de Sécurité Sanitaire des Aliments (AFSSA), Laboratoire d'Etudes et de Recherches Caprines, Niort, France,3 Mycoplasma Group, Statutory and Exotic Bacterial Diseases Department, Veterinary Laboratories Agency (Weybridge), Surrey, United Kingdom,4 Department of Biotechnology and Genetic Engineering, University of Nizwa, Barkat Al Mauz, Nizwa Sultanate of Oman5

Received 27 March 2007/ Returned for modification 28 May 2007/ Accepted 10 July 2007

MICs were determined for 15 antimicrobial agents against 37 Mycoplasma putrefaciens isolates. The most effective antimicrobial drug classes were the fluoroquinolones, the tetracyclines, the lincosamide lincomycin, and the macrolides. The susceptibility profile of the isolates correlated with the geographic origin. This is the first report of decreased susceptibility to the macrolides, lincomycin, and the tetracyclines in M. putrefaciens strains.

* Corresponding author. Mailing address: Unidad de Epidemiología y Medicina Preventiva, Instituto Universitario de Sanidad Animal (IUSA), Universidad de Las Palmas de Gran Canaria Trasmontaña s/n, 35416 Arucas, Spain. Phone: 34 928 45 97 17. Fax: 34 928 45 11 42. E-mail: nuno.giao101{at}doctorandos.ulpgc.es

{triangledown} Published ahead of print on 16 July 2007.

Antimicrobial Agents and Chemotherapy, September 2007, p. 3452-3454, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.00420-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»